P27 does not predict histopathological response to radiochemotherapy in rectal cancer

Journal of Surgical Research

Volumn 113, Issue 2, 2003, Pages 179-188

  Günther, Klaus ^a   Dimmler, Arno ^a   Rödel, Franz ^a   Reulbach, Udo ^a   Merkel, Susanne ^a   Bittorf, Birgit R ^a   Matzel, Klaus E ^a   Papadopoulos, Thomas ^a   Hohenberger, Werner ^a   Sauer, Rolf ^a   Rödel, Claus ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Neoadjuvant radiochemotherapy; P27kip1; Prediction of response; Rectal cancer; Tumor marker; Tumor regression

Indexed keywords

FLUOROURACIL; FOLINIC ACID; PROTEIN P27; TUMOR MARKER;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL CYCLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CANCER; STAINING; TUMOR BIOPSY; TUMOR REGRESSION;

EID: 0042384391     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00049-0     Document Type: Article

References (52)

1. Pahlman L. Neoadjuvant and adjuvant radio- and radio-chemotherapy of rectal carcinomas. Int. J. Colorectal Dis. 15:2000;1.
2. Rödel C., Grabenbauer G.G., Schick C., Papadopoulos T., Hohenberger W., Sauer R. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Strahlenther Onkol. 176:2000;161.
3. Videtic G.M., Fisher B.J., Perera F.E., Bauman G.S., Kocha W.I., Taylor M., Vincent M.D., Plewes E.A., Engel C.J., Stitt L.W. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 42:1998;319.
4. Hyams D.M., Mamounas E.P., Petrelli N., Rockette H., Jones J., Wieand H.S., Deutsch M., Wickerham L., Fisher B., Wolmark N. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum A progress report of National Surgical Breast and Bowel Project Protocol R-03 . Dis. Colon Rectum. 40:1997;131.
5. Wagman R., Minsky B.D., Cohen A.M., Guillem J.G., Paty P.P. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis Long term follow-up . Int. J. Radiat. Oncol. Biol. Phys. 42:1998;51.
6. Minsky B.D., Cohen A.M., Kemeny N., Enker W.E., Kelsen D.P., Reichman B., Saltz L., Sigurdson E.R., Frankel J. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J. Clin. Oncol. 10:1992;79.
7. Francois Y., Nemoz C.J., Baulieux J., Vignal J., Grandjean J.P., Partensky C., Souquet J.C., Adeleine P., Gerard J.P. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer the Lyon R90-01 randomized trial . J. Clin. Oncol. 17:1999;2396.
8. Sauer R., Fietkau R., Wittekind C., Martus P., Rödel C., Hohenberger W., Jatzko G., Sabitzer H., Karstens J.H., Becker H., Hess C., Raab R. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol. 177:2001;173.
9. Dworak O., Keilholz L., Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 12:1997;19.
10. Minsky B.D. Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis. Semin. Radiat. Oncol. 8:1998;30.
11. Ahmad N.R., Nagle D.A. Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by local excision. Semin. Radiat. Oncol. 8:1998;36.
12. Habr-Gama A., de Souza P.M., Ribeiro U. Jr., Nadalin W., Gansl R., Sousa A.H. Jr., Campos F.G., Gama-Rodrigues J. Low rectal cancer Impact of radiation and chemotherapy on surgical treatment . Dis. Colon Rectum. 41:1998;1087.
13. Elsaleh H., Robbins P., Joseph D., Powell B., Grieu F., Menso L., Iacopetta B. Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer. Radiother. Oncol. 56:2000;239.
14. Adell G., Sun X.F., Stal O., Klintenberg C., Sjodahl R., Nordenskjold B. p53 status an indicator for the effect of preoperative radiotherapy of rectal cancer . Radiother. Oncol. 51:1999;169.
15. Nehls O., Klump B., Holzmann K., Lammering G., Borchard F., Gruenagel H.H., Gaco V., Gregor M., Porschen R. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma. Cancer. 85:1999;2541.
16. Scott N., Hale A., Deakin M., Hand P., Adab F.A., Hall C., Williams G.T., Elder J.B. A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy Relationship to apoptotic activity, p53 and bcl-2 expression . Eur. J. Surg. Oncol. 24:1998;169.
17. Tannapfel A., Nusslein S., Fietkau R., Katalinic A., Köckerling F., Wittekind C. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;585.
18. Willett C.G., Warland G., Hagan M.P., Daly W.J., Coen J., Shellito P.C., Compton C.C. Tumor proliferation in rectal cancer following preoperative irradiation. J. Clin. Oncol. 13:1995;1417.
19. Qiu H., Sirivongs P., Rothenberger M., Rothenberger D.A., Garcia-Aguilar J. Molecular prognostic factors in rectal cancer treated by radiation and surgery. Dis. Colon Rectum. 43:2000;451.
20. Desai G.R., Myerson R.J., Higashikubo R., Birnbaum E., Fleshman J., Fry R., Kodner I., Kucik N., Lacey D., Ribeiro M. Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy. Dis. Colon Rectum. 39:1996;1090.
21. Belluco C., Esposito G., Bertorelle R., Del Mistro A., Fassina A., Vieceli G., Chieco-Bianchi L., Nitti D., Lise M. Absence of the cell cycle inhibitor p27Kip1 protein predicts poor outcome in patients with stage I-III colorectal cancer. Ann. Surg. Oncol. 6:1999;19.
22. Belluco C., Esposito G., Vieceli G., Bertorelle R., Fassina A., Fedeli U., Del Mistro A., Chieco-Bianchi L., Nitti D., Lise M. Cell cycle inhibitors and prognosis in T2-3N0M0 colorectal cancer. Eur. Surg. Res. 30:(Suppl):1998;74.
23. Günther K., Jung A., Völker U., Meyer M., Brabletz T., Matzel K.E., Reymond M.A., Kirchner T., Hohenberger W. p27(kip1) expression in rectal cancer correlates with disease-free survival. J. Surg. Res. 92:2000;78.
24. Hirano K., Minamoto T. Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum - a comparative clinicopathologic and molecular analysis. Cancer Detect. Prev. 24:2000;343.
25. Loda M., Cukor B., Tam S.W., Lavin P., Fiorentino M., Draetta G.F., Jessup J.M., Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3:1997;231.
26. Palmqvist, R., Stenling, R., Oberg, amd Landberg, G. Prognostic significance of p27(Kip1) expression in colorectal cancer: A clinico-pathological characterization. J. Pathol. 188: 18, 1999.
27. Tenjo T., Toyoda M., Okuda J., Watanabe I., Yamamoto T., Tanaka K., Ohtani M., Nohara T., Kawasaki H., Tanigawa N. Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas. Oncology. 58:2000;45.
28. Thomas G.V., Szigeti K., Murphy M., Draetta G., Pagano M., Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am. J. Pathol. 153:1998;681.
29. Yao J., Eu K.W., Seow-Choen F., Cheah P.Y. Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas. Int. J. Cancer. 89:2000;213.
30. Zhang H., Sun X.F. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. Int. J. Oncol. 19:2001;49.
31. Esposito G., Pucciarelli S., Alaggio R., Giacomelli L., Marchiori E., Iaderosa G.A., Friso M.L., Toppan P., Chieco-Bianchi L., Lise M. p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann. Surg. Oncol. 8:2001;311.
32. WHO. International Classification of Diseases for Oncology (ICD-O): WHO Publications, 1991.
33. Jass J.R., Sobin L.H., Watanabe H. The World Health Organization's Histologic Classification of Gastrointestinal Tumors - A Commentary on the Second Edition. Cancer. 66:1990;2162.
34. TNM Classification of Malignant Tumours. 1997;Wiley-Liss, New York.
35. Santoni-Rugiu E., Jensen M.R., Factor V.M., Thorgeirsson S.S. Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-betal signaling disruption. Am. J. Pathol. 154:1999;1693.
36. Vlach J., Hennecke S., Alevizopoulos K., Conti D., Amati B. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15:1996;6595.
37. Vlach J., Hennecke S., Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:1997;5334.
38. Sheaff R.J., Groudine M., Gordon M., Roberts J.M., Clurman B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1997;1464.
39. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682.
40. Mal A., Poon R.Y., Howe P.H., Toyoshima H., Hunter T., Harter M.L. Inactivation of p27kip1 by the viral E1A oncoprotein in TGFbeta-treated cells. Nature. 380:1996;262.
41. Polyak K., Kato J.Y., Solomon M.J., Sherr C.J., Massague J., Roberts J.M., Koff A. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9.
42. Orend G., Hunter T., Ruoslahti E. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene. 16:1998;2575.
43. Singh S.P., Lipman J., Goldman H., Ellis F.H. Jr., Aizenman L., Cangi M.G., Signoretti S., Chiaur D.S., Pagano M., Loda M. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 58:1998;1730.
44. Capodieci P., Gerald W., Woodruff J., Cordon-Cardo C., Koff A. Cytoplasmic localization of p27kip1 in sarcoma. Proc. Am. Assoc. Cancer Res. 40:1999;687.
45. Claret F.X., Hibi M., Dhut S., Toda T., Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature. 383:1996;453.
46. Tomoda K., Kubota Y., Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27kip1 is instigated by Jab1. Nature. 398:1999;160.
47. Fredersdorf S., Burns J., Milne A.M., Packham G., Fallis L., Gillett C.E., Royds J.A., Peston D., Hall P.A., Hanby A.M., Barnes D.M., Shousha S., MJ O.H., Lu X. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers . Proc. Natl. Acad. Sci. U. S. A. 94:1997;6380.
48. Brabletz T., Jung A., Hermann K., Günther K., Hohenberger W., Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol. Res. Pract. 194:1998;701.
49. Palmqvist R., Sellberg P., Oberg A., Tavelin B., Rutegard J.N., Stenling R. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers. Br. J. Cancer. 79:1999;577.
50. Feakins R.M., Mulcahy H.E., Quaglia A., Jawhari A., Zhang Z., Patchett S.E. p27(Kip1) loss does not predict survival in patients with advanced gastric carcinoma. Cancer. 89:2000;1684.
51. Barbareschi M., van Tinteren H., Mauri F.A., Veronese S., Peterse H., Maisonneuve P., Caffo O., Scaioli M., Doglioni C., Galligioni E., Dalla Palma P., Michalides R. p27(kip1) expression in breast carcinomas An immunohistochemical study on 512 patients with long-term follow-up . Int. J. Cancer. 89:2000;236.
52. Nycum L.R., Smith L.M., Farley J.H., Kost E.R., Method M.W., Birrer M.J. The role of p27 in endometrial carcinoma. Gynecol. Oncol. 81:2001;242.